INBS Intelligent Bio Solutions Inc.

$2.13▼ -2.74% Healthcare Other
After hours $2.16▲ +1.17% Sep 11, 7:59 PM ET
Volume 30.1K Avg Volume (10D) 567.7K
Key Metrics & Fundamentals
Market Cap
$6.45M
P/E Ratio
–
Div Yield
–%
52W Range
1.52 - 24.90
% vs 50 MA
-3.40%
% vs 200 MA
-50.55%
RSI-14
43.7
MACD Histogram
-0.0500
Beta (1Y vs SPY)
0.79
Free Cash Flow
-$3.18M
Gross Rev
$1.15M
Gross Profit
$536,583
EBITDA
-$3.63M
COGS
$609,219
Operating Exp
$4.50M
Operating Income
-$3.96M
EBIT
-$3.96M
Pretax Income
-$3.92M
Net Income
-$3.91M
Price & Volume History
Loading chart…
Recent News
Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET
GlobeNewswire · Sep 10, 2026 12:30 PM
Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market
Benzinga · Sep 9, 2026 12:31 PM
Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance
GlobeNewswire · Sep 9, 2026 12:30 PM
Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission
GlobeNewswire · Sep 1, 2026 12:31 PM
Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules
GlobeNewswire · Sep 1, 2026 12:30 PM
Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth
GlobeNewswire · Aug 19, 2026 12:30 PM
Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification
GlobeNewswire · Aug 17, 2026 12:30 PM
Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System
GlobeNewswire · Aug 11, 2026 12:30 PM
Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission
GlobeNewswire · Aug 5, 2026 12:30 PM
Intelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances on Intelligent Fingerprinting System
GlobeNewswire · Aug 3, 2026 12:30 PM
Financial Overview - Income Statement Quarterly

See INBS's money flow as a full page

Social Sentiment
Avg +0.74 · 5 posts
NewsDiscussionTradeDDThe future of drug testing. Intelligent Bio Solutions. Symbol: INBS
r/wallstreetbets · Oct 23, 2025
The post highlights the product's innovation, market demand, and potential growth driven by legalization.
positive +0.80
INBS ($2.01) This hidden gem is headed for greatness this year.
r/stocks · Feb 7, 2025
The post contains positive sentiment regarding the stock's future, suggesting a bullish outlook.
positive +0.60
DDNewsDiscussionINBS ($1.95) This hidden gem is headed for greatness this year.
r/StockMarket · Feb 7, 2025
The author expresses strong bullish sentiment and highlights a pending FDA approval and potential market impact.
very_positive +0.80
NewsDiscussionI'm done with AI stocks for awhile. Anyone here care to recommend a good non-ai stock?
r/StockMarket · Feb 4, 2025
Author explicitly states ownership and positive attributes of the company's product, with potential FDA approval.
positive +0.70
DDNewsDiscussionPriceTargetINBS ($1.60) This could be a major runner. Could it be a 10x bagger?
r/StockMarket · Jan 31, 2025
The post expresses high expectations for the stock's potential, citing a large float and high short interest, suggesting a significant upward movement.
very_positive +0.80
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙